View the LUCINFIG registration information details.
Back to drug list
ItemsDrug Registration information
ID1756
No1756
Brand NameLUCINFIG
IngredientsINFIGRATINIB 25 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 63'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF ADULTS WITH PREVIOUSLY TREATED, UNRESECTABLE LOCALLY ADVANCED ORMETASTATIC CHOLANGIOCARCINOMA WITH A FIBROBLAST GROWTH FACTOR RECEPTOR 2 FUSION OR OTHER REARRANGEMENT
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionBLUE-WHITE CAPSULE CONTAINS WHITE POWDER
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 L 1339/25
FDD Registration Date45768
Expiry Date47593
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA